Update from KAITLIN for high-risk HER2-positive early breast cancer

CARTITUDE-1: JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell therapy for r/r multiple myeloma

Sym015 shows superior specificity compared to TKIs for NSCLC

Brigatinib for NSCLC, latest research and overcoming complications

COVID-19: Treating breast cancer and the knock on effects of the coronavirus pandemic

Pembrolizumab plus chemotherapy for patients with metastatic triple-negative breast cancer

Conducting Oncology Clinical Trials in Africa II: AC3T - Assessing, profiling, and building cancer clinical trial capacity in Africa

Perioperative use of NSAIDs reduces risk of early relapse in breast cancer

COVID-19: Using oncology drugs and surgery during the coronavirus pandemic

TERAVOLT: Thoracic cancers indicate an unexpectedly high mortality rate in patients with COVID-19

IMPRIME 1: Combination of pembrolizumab and a novel innate immune activator, Imprime PGG, in second-line mTNBC

Concomitant use of antibiotics and immune checkpoint inhibitors in patients with solid neoplasms